AASLD

03/05/2026

At DDW®, AASLD offers programming designed for the entire GI community, addressing liver conditions encountered in everyday practice, from MASLD and MASH to complex metabolic interactions.

Join the Basic Science Emerging Topic Conference, chaired by Savneet Kaur, PhD, Cristina Llorente, PhD, and Marti Ortega Ribera, PhD, to explore how systems-level science is shaping patient care.

Limited availability — start building your experience today! While you’re planning, don’t miss our hands-on POCUS sessions — a must-attend favorite! https://bit.ly/3OPoGNP

03/04/2026

Stay ahead of HBV reactivation.

Join us tomorrow as Robert Gish, MD, and Kristine Drozd, MSN, NP-C, break down the latest guidance and real-world strategies to protect immunosuppressed patients.

Leave ready to put the guidance into practice.

CME available 👉 https://bit.ly/3PhFQ6M

03/04/2026

Interested in clinical informatics, digital health, or data-driven care? AASLD’s new Clinical Informatics and Digital Health Special Interest Group (CIDH SIG) brings together multidisciplinary experts to collaborate, learn, and help shape the future of liver disease research and care.

Learn more about AASLD’s newest SIG and how to get involved: https://bit.ly/3OigJk8

03/03/2026

Liver disease is a global challenge, and advancing care starts with understanding how is practiced worldwide.

Participate in the Global Hepatology Survey, launched in collaboration with EASL - The Home of Hepatology, ALEH - Asociación Latinoamericana para el Estudio del Hígado, SOLDA - Society on Liver Disease in Africa and the Asian Pacific Association for the Study of the Liver.

🗓 Open through March 31, 2026
🌍 Available in 4 languages
👉 https://bit.ly/4rOPJHI

Your voice helps shape global collaboration.

Take this survey powered by surveymonkey.com. Create your own surveys for free.

03/03/2026

Three days left to apply for AASLD’s 2026 Transplant Hepatology Fellowship Matching Program! Pursue eligibility for an and/or certification early when you match with a transplant hepatology fellowship. Applications close at 8 p.m. EST on March 6. https://bit.ly/3oQOYQo

03/03/2026

Unlocking the Future of Liver Safety 💊

Drug-induced liver injury (DILI) is one of the most unpredictable forms of hepatic disease, with patient responses varying widely.
Led by Professor Takanori Takebe, MD, PhD, Endowed Chair of Organoid Medicine at Cincinnati Children’s Hospital and deputy director of WPI-PRIMe at Osaka University, this seminar is proposing an integrative pre-clinical approach that combines patient-derived and engineered human tissues using cutting-edge technologies like:

✔️ Comprehensive genomics
✔️ Gene editing
✔️ Induced pluripotent stem cells
✔️ Organoids

By introducing population-based organoid systems, Dr. Takebe wants to uncover why some individuals are more susceptible than others, accelerating the future of precision hepatotoxicology.

Register now 👉 https://bit.ly/4bkmK8J

03/03/2026

Liver disease is a global challenge, and advancing care starts with understanding how is practiced worldwide.

Participate in the Global Hepatology Survey, launched in collaboration with , , , and .

🗓 Open through March 31, 2026
🌍 Available in 4 languages
👉 https://bit.ly/4rOPJHI

Your voice helps shape global collaboration.

03/02/2026

AASLD is proud to collaborate with leading global organizations on a new consensus document guiding the diagnosis, staging, and management of alpha-1 antitrypsin deficiency–associated liver disease in adults.

Developed by a multinational, multidisciplinary expert panel and published in Gastroenterology, this landmark guidance reinforces AASLD’s leadership in advancing evidence-based care and accelerating research to improve outcomes for patients worldwide.

View the consensus document. https://bit.ly/4snHRNl

03/02/2026

Now Open: 2026 Distinguished Award Nominations

Honor the leaders advancing hepatology! AASLD’s most prestigious Distinguished Awards recognize sustained excellence in science, education, service, and advocacy. Recipients will be celebrated at The Liver Meeting® 2026 in Denver, CO.

Learn more about the awards and start your nomination: https://bit.ly/3MD0xJN

03/01/2026

In celebration of , AASLD is spotlighting research that advances understanding of women’s and strengthens equity across .

Explore this curated collection from all three journals, , , and . ⬇️

https://bit.ly/3ZsOS0I

02/28/2026

Today is . At AASLD, we are committed to advancing education, research, and advocacy that support individuals living with rare .

View these perspectives from AASLD members who are driving progress in rare liver disease research, diagnosis, and care. Their insights highlight both the urgent challenges and the powerful opportunities shaping the future of .

02/27/2026

AASLD's commitment to advocacy, education, and research is shaping the future of , and we are seeking dedicated leaders to build on the momentum. Peer or self-nominate before March 1. Nominate now >> https://bit.ly/4gzeHV8